Rani Therapeutics Holdings, Inc. - Class A Common Stock — Cash Flow (NASDAQ:RANI) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -32.24 M-46.52 M-51.24 M-35.5 M-18.71 M -17.06 M Cash from investing activities -506 K-72.44 M29.86 M19.81 M-7.03 M -27.71 M Cash from financing activities 77.15 M29 M233 K13.59 M40.3 M 44 M Free cash flow -32.24 M-46.52 M-51.24 M-35.5 M-18.8 M -17.11 M

News

Rani Therapeutics Holdings, Inc. (RANI) Q4 2025 Earnings Call Transcript

Rani Therapeutics promotes Alireza Javadi to chief technical officer

Rani Therapeutics begins phase 1 trial of oral obesity treatment

Rani Therapeutics amends charter, reduces Class B voting power and ends tax agreement

Rani Therapeutics announces $1.085 billion Chugai collaboration

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.09%

Monday’s Insider Moves: Top Buys and Sells in US Stocks on October 27

Rani Therapeutics director Imran Mir a buys $1.26 million in stock

Rani Therapeutics appoints new directors and closes private placement

Rani Therapeutics adds two biotech investors to board of directors

Rani Therapeutics closes $60.3 million private placement

South Cone investments sells Rani Therapeutics (RANI) shares for $15.7m